Abstract
Lecithin:cholesterol acyltransferase (LCAT) is the enzyme responsible for generation of the majority of the cholesteryl esters (CE) in human plasma. Although most plasma cholesterol esterification occurs on high-density lipoprotein (HDL), via α-LCAT activity, esterification also occurs on low-density lipoprotein (LDL) via the β-activity of the enzyme. Computer threading techniques have provided a three-dimensional model for use in the structure-function analysis of the core and catalytic site of the LCAT protein, but the model does not extend to the N-terminal region of the enzyme, which may mediate LCAT interaction with lipoprotein substrates. In the present study, we have examined the functional consequences of deletion of the highly conserved hydrophobic N-terminal amino acids (residues 1-5) of human LCAT. Western blot analysis showed that the mutant proteins (Δ1-Δ5) were synthesized and secreted from transfected COS-7 cells at levels approximately equivalent to those of wild-type hLCAT. The secreted proteins had apparent molecular weights of 67 kDa, indicating that they were correctly processed and glycosylated during cellular transit. However, deletion of the first residue of the mature LCAT protein (Δ1 mutant) resulted in a dramatic loss of α-LCAT activity (5% of wild type using reconstituted HDL substrate, rHDL), although this mutant retained full β-LCAT activity (108% of wild-type using human LDL substrate). Removal of residues 1 and 2 (Δ2 mutant) abolished α-LCAT activity and reduced β-LCAT activity to 12% of wild type. Nevertheless, LCATΔ1 and Δ2 mutants retained their ability to bind to rHDL and LDL lipoprotein substrates. The dramatic loss of enzyme activity suggests that the N-terminal residues of LCAT may be involved in maintaining the conformation of the lid domain and influence activation by the α-LCAT cofactor apoA-I (in Δ1) and/or loss of enzyme activity (in Δ1-Δ5). Since the Δ1 and Δ2 mutants retain their ability to bind substrate, other factor(s), such as decreased access to the substrate binding pocket, may be responsible for the loss of enzyme activity.
Original language | English |
---|---|
Pages (from-to) | 164-172 |
Number of pages | 9 |
Journal | Biochimica et Biophysica Acta - Proteins and Proteomics |
Volume | 1646 |
Issue number | 1-2 |
DOIs | |
Publication status | Published - Mar 21 2003 |
Bibliographical note
Funding Information:The authors thank Drs. Jeff Chisholm and John Parks (Wake Forest University, Winston-Salem, NC) for providing LCAT cDNA plasmids used for mutagenesis, and Dr. Ross Milne (Ottawa Heart Institute, ON, Canada) for providing the monoclonal antibody to human LCAT. This work was supported by the Canadian Institutes of Health Research (CIHR), Grant Number MT-5999 to Dr. Peter Dolphin (deceased June 22, 2001) and the manuscript is dedicated to his memory.
ASJC Scopus Subject Areas
- Analytical Chemistry
- Biophysics
- Biochemistry
- Molecular Biology
PubMed: MeSH publication types
- Journal Article
- Research Support, Non-U.S. Gov't